• 1
    Goff BA, Matthews B, Andrilla CHA, et al. How are symptoms of ovarian cancer managed? A study of primary care physicians. Cancer. 2011; 117: 4414-4423.
  • 2
    Jacobs IJ, Menon U. Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics. 2004; 3: 355-366.
  • 3
    Bast RC Jr, Brewer M, Zou C, et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007; 174: 91-100.
  • 4
    Kim MK, Kim K, Kim SM, Prk NH, Song YS, Kang SB. A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol. 2009; 20: 238-242.
  • 5
    Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004; 291: 2705-2712.
  • 6
    Menon U, Gentry-Maharaj A, Hallett R, et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol. 2009; 10: 327-340.
  • 7
    Brown PO, Palmer C. The preclinical natural history of serous ovarian cancer: defining the target for early detection [serial online]. PLOS Med. 2009; 6: e1000114.
  • 8
    Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IeM. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol. 2008; 198: 351-356.
  • 9
    Christie M, Oehler MK. Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc. 2006; 12: 57-63.
  • 10
    Bell DA. Origins and molecular pathology of ovarian cancer. Mod Pathol. 2005; 18( suppl 2): S19-S32.
  • 11
    Seidman JD, Zhao P, Yemelyanova A. “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer [published online ahead of print December 13, 2010]. Gynecol Oncol. 2010.
  • 12
    Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R. Are all pelvic (nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol. 2010; 34: 1407-1416.
  • 13
    Carlson JW, Miron A, Jarboe EA, et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol. 2008; 26: 4160-4165.
  • 14
    Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010; 34: 433-443.
  • 15
    Takashina T, Ono M, Kanda Y, Sagae S, Hayakawa O, Ito E. Cervicovaginal and endometrial cytology in ovarian cancer. Acta Cytol. 1988; 32: 159-162.